Chemical proteomics-driven discovery of oleocanthal as an Hsp90 inhibitor
- 9 May 2013
- journal article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 49 (52), 5844-5846
- https://doi.org/10.1039/c3cc41858h
Abstract
Hsp90, a key target in cancer therapy, has been identified as the main partner of oleocanthal, an olive oil bioactive compound. A combination of chemical and biological assays disclosed its mechanism of action at the molecular level.This publication has 31 references indexed in Scilit:
- Direct Measurement of Oleocanthal and Oleacein Levels in Olive Oil by Quantitative 1H NMR. Establishment of a New Index for the Characterization of Extra Virgin Olive OilsJournal of Agricultural and Food Chemistry, 2012
- Heat shock proteins as key biological targets of the marine natural cyclopeptide perthamide CMolecular BioSystems, 2012
- New insights on the interaction mechanism between tau protein and oleocanthal, an extra-virgin olive-oil bioactive componentFood & Function, 2011
- Oleuropein and derivatives from olives as Tau aggregation inhibitorsNeurochemistry International, 2011
- Heat shock protein 90 in neurodegenerative diseasesMolecular Neurodegeneration, 2010
- Chemical Proteomics Discloses Petrosapongiolide M, an Antiinflammatory Marine Sesterterpene, as a Proteasome InhibitorAngewandte Chemie, 2010
- Targeting Hsp90 with small molecule inhibitors induces the over-expression of the anti-apoptotic molecule, survivin, in human A549, HONE-1 and HT-29 cancer cellsMolecular Cancer, 2010
- Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tauJournal of Neurochemistry, 2009
- Mass spectrometry for proteomicsCurrent Opinion in Chemical Biology, 2008
- Oleocanthal in olive oil: Between myth and realityMolecular Nutrition & Food Research, 2006